Systemic Lupus Erythematosus: Clinical Features and Management

Abstract

Systemic Lupus Erythematosus (SLE) is a chronic, multisystem autoimmune disease characterized by the production of autoantibodies and the formation of immune complexes, which can lead to widespread inflammation and tissue damage. SLE predominantly affects women of childbearing age, with a female-to-male ratio of approximately 9:1, and tends to be more prevalent and severe among individuals of African, Hispanic, and Asian descent. Close monitoring and a multidisciplinary approach are essential to reduce disease activity, prevent flares, and improve long-term outcomes. Early diagnosis and individualized treatment plans contribute significantly to reducing morbidity and improving quality of life for patients with SLE.